Impact of tumor-infiltrating lymphocytes on response to neoadjuvant chemotherapy in triple-negative early breast cancer: Translational subproject of the WSG-ADAPT TN trial
In: Journal of Clinical Oncology, Jg. 36 (2018-05-20), S. 12102-12102
Online
unknown
Zugriff:
12102Background: In triple-negative breast cancer (TNBC), pathological complete response (pCR, ypT0/is/ypN0) is associated with improved prognosis. The randomized prospective WSG-ADAPT TN phase II ...
Titel: |
Impact of tumor-infiltrating lymphocytes on response to neoadjuvant chemotherapy in triple-negative early breast cancer: Translational subproject of the WSG-ADAPT TN trial
|
---|---|
Autor/in / Beteiligte Person: | Würstlein, Rachel ; Feuerhake, Friedrich ; Aktas, Bahriye ; Kates, Ronald E. ; Gluz, O ; Liedtke, Cornelia ; Hackmann, C ; Garke, M ; Kreipe, H.H. ; Grischke, EM ; Schumacher, Claudia ; Harbeck, Nadia ; Christgen, Matthias ; Kuemmel, S. ; Nitz, U ; Forstbauer, Helmut ; Uleer, Christoph ; Warm, M ; Braun, Michael |
Link: | |
Zeitschrift: | Journal of Clinical Oncology, Jg. 36 (2018-05-20), S. 12102-12102 |
Veröffentlichung: | American Society of Clinical Oncology (ASCO), 2018 |
Medientyp: | unknown |
ISSN: | 1527-7755 (print) ; 0732-183X (print) |
DOI: | 10.1200/jco.2018.36.15_suppl.12102 |
Schlagwort: |
|
Sonstiges: |
|